Clinical Trials Browser

OTHER_GOV × Carcinoma, Non-Small-Cell Lung × Thalidomide × Clear all

NCT06231680 2024-03-29

Thalidomide Prevention or Treatment of Camrelizumab-induced Reactive Cutaneous Capillary Endothelial Proliferation (RCCEP)

Phase 2 Unknown

GastrointestinalThoracic

Carcinoma, Non-Small-Cell Lung, Esophageal Neoplasms

NCT03341494 2017-11-14

EGFR Mutation Positive NSCLC Patients With Gefitinib and Thalidomide

Phase 2 Unknown

Carcinoma, Non-Small-Cell Lung